Clinical Trials Browser

Withdrawn × Lymphoma × 30 days × Clear all

NCT07453446 2026-05-06

Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

Phase 1 Withdrawn

Lymphoma, Recurrence